Andrew Paul Mazar
Chief Executive Officer, Monopar Therapeutics.
Companies
- ACTUATE THERAPEUTICS, INC.Chief operating officer Aug 12, 2024 to now1
- Monopar TherapeuticsBoard member Jan 8, 2018 to Apr 1, 20222
- Monopar TherapeuticsChief Scientific Officer Jan 8, 2018 to Apr 1, 20223
- Monopar TherapeuticsChief executive officer Jan 8, 2018 to Feb 16, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Monopar Therapeutics MNPR188,792 shares4$13.4M at $70.76Apr 1, 2022- ACTUATE THERAPEUTICS, INC. ACTU127,250 shares5$76.0K at $0.60Aug 12, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 31, 2022Shares withheld for tax 471 shares at $2.55 of Monopar Therapeutics4
- Mar 31, 2022Exercised options 1,606 shares of Monopar Therapeutics4
- Jan 1, 2022Shares withheld for tax 671 shares at $3.21 of Monopar Therapeutics6
- Jan 1, 2022Exercised options 1,937 shares of Monopar Therapeutics6
- Dec 31, 2021Shares withheld for tax 556 shares at $3.21 of Monopar Therapeutics7
- Dec 31, 2021Exercised options 1,606 shares of Monopar Therapeutics7
- Sep 30, 2021Shares withheld for tax 471 shares at $4.87 of Monopar Therapeutics8
- Sep 30, 2021Exercised options 1,606 shares of Monopar Therapeutics8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARMonopar Therapeutics, Board member
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Jan 4, 2022
- 7SEC EDGARForm 4 filed Jan 4, 2022
- 8SEC EDGARForm 4 filed Oct 1, 2021